CDKN2A and melanoma: The most significantly enriched alterations in BRAF-mutant compared with non-BRAF-mutant melanomas were non-duplication SV events in CDKN2A (39/81, 48%; Fisher’s exact, OR = 2.41, 95% CI = 1.24–4.78, P = 7.8 × 10–3).